Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Connors

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Blood|July 1, 1997
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphomaR D Gascoyne, S A Adomat, S Krajewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Current Oncology (Toronto, Ont.)|November 3, 2016
A time-and-motion approach to micro-costing of high-throughput genomic assaysS Costa, D A Regier, B Meissner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphomaD A Macdonald, K Ding, M K Gospodarowicz, et al.
Blood|May 26, 1999
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphomaR D Gascoyne, P Aoun, D Wu, et al.
The New England Journal of Medicine|June 15, 2000
Thrombotic thrombocytopenic purpura associated with clopidogrelC L Bennett, J M Connors, J M Carwile, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials groupJ M Connors, P Klimo, G Adams, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Blood|July 1, 1997
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphomaR D Gascoyne, S A Adomat, S Krajewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Current Oncology (Toronto, Ont.)|November 3, 2016
A time-and-motion approach to micro-costing of high-throughput genomic assaysS Costa, D A Regier, B Meissner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphomaD A Macdonald, K Ding, M K Gospodarowicz, et al.
Blood|May 26, 1999
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphomaR D Gascoyne, P Aoun, D Wu, et al.
The New England Journal of Medicine|June 15, 2000
Thrombotic thrombocytopenic purpura associated with clopidogrelC L Bennett, J M Connors, J M Carwile, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphomaD D Weisenburger, R D Gascoyne, P J Bierman, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials groupJ M Connors, P Klimo, G Adams, et al.
Pageof 16